Cerebrospinal fluid pharmacokinetics of the antituberculosis drugs. 1985

M R Holdiness

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

M R Holdiness
January 1983, Pediatric pharmacology (New York, N.Y.),
M R Holdiness
October 1998, The Annals of pharmacotherapy,
M R Holdiness
January 1987, Journal of clinical pharmacology,
M R Holdiness
January 1989, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
M R Holdiness
January 2008, Current medicinal chemistry,
M R Holdiness
January 1982, Clinical pharmacokinetics,
M R Holdiness
October 1988, Presse medicale (Paris, France : 1983),
M R Holdiness
September 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
M R Holdiness
September 2010, Tuberculosis (Edinburgh, Scotland),
Copied contents to your clipboard!